SMG
The Scotts Miracle-Gro Company58.62
+0.13+0.22%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
3.40BP/E (TTM)
23.73Basic EPS (TTM)
2.47Dividend Yield
0.05%Recent Filings
10-K
FY2025 results
Scotts Miracle-Gro posted FY2025 net sales of $3.4B, down 3.9% y/y from $3.6B, yet swung to net income of $145.2M ($2.47 diluted EPS) from a $34.9M loss, fueled by gross margin expansion to 30.6% from 23.9% via lower material costs and favorable U.S. Consumer mix. U.S. Consumer dipped 0.7% to $3.0B on nonrecurring sales drop but lifted segment profit 15% to $573M; Hawthorne cratered 44% to $166M yet turned profitable at $2.8M amid cannabis oversupply. Q4 mirrored seasonality at 11% of sales. Debt fell to $2.1B (leverage 4.10x) with $1.2B revolver capacity; dividends held steady, no buybacks. Cannabis oversupply clouds Hawthorne momentum.
8-K
Scotts refinances $2B credit facility
8-K
RSUs replace exec cash incentives
Scotts Miracle-Gro will grant restricted stock units to executives and key employees starting November 13, 2025, under its Long-Term Incentive Plan. These RSUs replace cash payouts for the fiscal year ended September 30, 2025, vesting 100% immediately on grant with net share settlement after tax withholding. Routine comp shift. No financial impact disclosed.
8-K
Strong FY25 margins, EPS growth
Scotts Miracle-Gro reported fiscal 2025 results on November 5, with U.S. Consumer net sales at $2.99 billion, adjusted gross margin up to 31.2%, and adjusted EPS surging to $3.74. Gross margins expanded sharply while Hawthorne sales plunged 44%. Fiscal 2026 eyes low single-digit U.S. sales growth, 32% adjusted margins. Debt leverage fell to 4.10x.
8-K
Extends $750M receivables facility
The Scotts Miracle-Gro extended its $750 million receivables facility with JPMorgan Chase Bank through a second amendment signed August 28, 2025, pushing the termination date from September 1, 2025, to September 1, 2026. This uncommitted setup lets subsidiaries sell eligible accounts receivable from five key customers weekly, with the company servicing them for a 20 basis point fee and using proceeds for general corporate needs. Backed by $75 million in standby letters of credit, the facility remains non-recourse except for standard repurchase duties. It secures ongoing liquidity amid receivables management.
IPO
Website
Employees
Sector
Industry
CENT
Central Garden & Pet Company
33.71-0.05
CTVA
Corteva, Inc.
65.48-0.40
EDBL
Edible Garden AG Incorporated
1.19+0.04
FMC
FMC Corporation
13.16+0.04
GRWG
GrowGeneration Corp.
2.15+0.24
HYFM
Hydrofarm Holdings Group, Inc.
2.44+0.40
MOS
Mosaic Company (The)
23.46-1.40
NMHI
Nature's Miracle Holding Inc.
0.08+0.01
NTR
Nutrien Ltd.
61.85+0.00
SANW
S&W Seed Co.
0.06+0.00